Wave Life Sciences Files 8-K
Ticker: WVE · Form: 8-K · Filed: Oct 16, 2024 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Oct 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Wave Life Sciences filed an 8-K on Oct 16, 2024. No major news yet, check full filing.
AI Summary
Wave Life Sciences Ltd. filed an 8-K on October 16, 2024, reporting on other events and financial statements. The filing does not contain specific details about new material events, significant financial changes, or executive actions, suggesting it may be a routine or placeholder filing.
Why It Matters
This 8-K filing from Wave Life Sciences Ltd. indicates a regulatory update. Investors should review the full document for any disclosed material events or financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K without immediate disclosure of significant negative events, suggesting a low immediate risk.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- October 16, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on other events and financial statements and exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is October 16, 2024.
What is the company's legal name and jurisdiction of incorporation?
The company's exact name is Wave Life Sciences Ltd., and it is incorporated in Singapore.
What is the Commission File Number for Wave Life Sciences Ltd.?
The Commission File Number for Wave Life Sciences Ltd. is 001-37627.
What are the business and mailing addresses provided for Wave Life Sciences Ltd.?
The business address is 7 Straits View #12-00, Marina One East Tower, Singapore. The mailing address is 733 Concord Avenue, Cambridge, MA 02138.
Filing Stats: 576 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-10-16 08:34:02
Key Financial Figures
- $0 — e of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d890226d8k.htm (8-K) — 25KB
- d890226dex991.htm (EX-99.1) — 15KB
- g890226g1016100000606.jpg (GRAPHIC) — 4KB
- 0001193125-24-237869.txt ( ) — 171KB
- wve-20241016.xsd (EX-101.SCH) — 3KB
- wve-20241016_lab.xml (EX-101.LAB) — 18KB
- wve-20241016_pre.xml (EX-101.PRE) — 11KB
- d890226d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Press Release issued by Wave Life Sciences Ltd. dated October 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD . By: /s/ Paul B. Bolno, M.D. Paul B. Bolno, M.D. President and Chief Executive Officer Date:October 16, 2024